Clinical Trial Update: The Use of GnRH Agonist Trigger in the Prevention of OHSS [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluates using a GnRH agonist trigger to prevent ovarian hyperstimulation syndrome. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• Gonadotropin-releasing hormone agonist trigger (Gonadotropin-releasing hormone agonist)

Snippet

Sponsor: University of Connecticut | Conditions: Ovarian Hyperstimulation Syndrome | Phase 4 | Status: COMPLETED